Conjugated Linoleic Acid

2 research sources Also known as: cla conjugated linoleic acid tonalin cla
134 Products on Market
1000.0 mg Median Dose
🟢 87/100 Market Safety Score
2 Research Sources
Browse 134 products →

Top-Rated Conjugated Linoleic Acid Products

View all Conjugated Linoleic Acid products → Best Conjugated Linoleic Acid rankings →

Evidence Summary

Conjugated Linoleic Acid (CLA) has been the subject of clinical investigations regarding its potential impact on atherosclerosis and general health. However, the provided research documentation focuses on study metadata rather than clinical outcomes.

Evidence by Condition

Atherosclerosis Insufficient

Clinical trials have been conducted to investigate the relationship between CLA and atherosclerosis, but specific results were not provided in the source text.

Effective Doses

Not specified in the provided research.

Key Findings

  • No specific findings or clinical results were reported in the provided text.

Limitations

The provided data only includes study parameters (such as enrollment and phase) and lacks the actual results, conclusions, or efficacy data from the trials.

Safety & Interactions

No information regarding safety, interactions, or contraindications was provided in the source text.

AI-generated summary from 2 peer-reviewed studies. Not medical advice. Always consult a healthcare provider.

Claims vs. Evidence

67% Evidence-Backed
33% Unsupported
84% Structure/Function
Claim Type% of ProductsEvidence RequiredStatus
All Other 99% Tier D (Unclassified) ✅ Supported
Structure/Function 84% Tier C (DSHEA Structure/Function (no pre-approval)) ⚠️ Unsupported
Nutrient 52% Tier D (Unknown) ✅ Supported

Research by Topic

Research Evidence (2)

Clinical Trial: 2
C Conjugated Linoleic Acid and Atherosclerosis
Clinical Trial ClinicalTrials.gov 2007

**NCT ID**: NCT00706745 **Phase**: PHASE3 **Status**: COMPLETED **Enrollment**: 401 **Completion**: 2008-12

C Conjugated Linoleic Acid Supplementation Study
Clinical Trial ClinicalTrials.gov 2010

**NCT ID**: NCT01234636 **Phase**: NA **Status**: COMPLETED **Enrollment**: 50 **Completion**: 2012-11

Frequently Asked Questions

What is Conjugated Linoleic Acid (CLA) and what is it used for?

Conjugated Linoleic Acid (CLA) is a type of fatty acid that has been studied for its potential impact on general health and atherosclerosis. Currently, there is insufficient evidence to confirm specific health benefits. (Strength: Weak)

Can CLA help prevent atherosclerosis?

There is insufficient evidence to determine if CLA is effective for atherosclerosis. While clinical trials have been conducted to investigate this relationship, specific clinical results are not yet established. (Strength: Weak)

What is the effective dose of CLA for health benefits?

The research does not specify an effective dose for CLA. Because clinical outcomes are not yet documented, a recommended dosage cannot be determined from the available data.

Is CLA safe to take?

There is no information available regarding the safety, side effects, or upper tolerable limits of CLA. You should consult a healthcare professional before adding this supplement to your routine.

Are there any known drug interactions with CLA?

There are currently no documented drug interactions for CLA in the available research. However, it is important to speak with a doctor if you are taking any prescription medications.

Who should avoid taking CLA?

The provided research does not identify specific groups of people or contraindications for CLA. Because safety data is limited, individuals with underlying health conditions should consult a physician first.

Does CLA have proven health benefits?

At this time, there are no specific clinical findings or proven health benefits reported for CLA. The evidence regarding its impact on health remains insufficient. (Strength: Weak)

Answers generated from research evidence. Not medical advice.